Newsroom
Category
July 5, 2016
A long-used drug called methylene blue may rev up activity in brain regions involved in short-term memory and attention, a small study suggests. Methylene blue has been used in medicine for more than a century, said Timothy Duong, the senior researcher on the study and a professor at the University of Texas Health Science Center at San Antonio.
June 3, 2016
Hepatitis C is the leading blood-borne disease in the U.S., with more than 3.5 million people developing a chronic infection. While the outlook for treating hepatitis C was grim just a few years ago, now most patients can be cured with direct-acting antiviral medications, many of them evaluated at the UT Health Science Center San Antonio.
June 3, 2016
The Cancer Therapy & Research Center has been named among the top 10 of the 990 institutions that are members of SWOG, an international network of researchers that design and conduct cancer clinical trials.
May 20, 2016
The Cancer Therapy & Research Center of the Health Science Center garnered $10.9 million from the Cancer Prevention & Research Institute of Texas (CPRIT)―a larger amount than any other academic institution in the state.
May 19, 2016
The San Antonio Life Sciences Institute (SALSI) has awarded $200,000 through its innovation grants to lead scientists at the Health Science Center and UTSA conducting research on technology solutions in health care.
May 11, 2016
Individuals with post-traumatic stress disorder (PTSD) relive past traumas again and again, bound in a virtual prison of their memories. Researchers in the School of Medicine at the Health Science Center now report a biological mechanism that might explain why these individuals are less able to extinguish the fear of past dangers.
